Why MDMA-assisted psychotherapy may become an FDA-approved treatment for PTSD within 2 years
This article was originally published on The Conversation.
To Learn More:
Study: Psychedelics can promote neural plasticity in the prefrontal cortex and expand pathways for mental health
FDA-approved, Cybin-sponsored clinicial trial to measure ketamine’s impact on the brain via Kernel Flow neuroimaging helmet
The post Why MDMA-assisted psychotherapy may become an FDA-approved treatment for PTSD within 2 years appeared first on SharpBrains.
Source: SharpBrains - Category: Neuroscience Authors: The Conversation Tags: Brain/ Mental Health antidepressants Cannabidiol cannabis CBD Ecstasy MDMA MDMA-assisted psychotherapy neural plasticity Physical assault post-traumatic-stress-disorder psilocybin PTSD Sexual assault street drugs substance-ab Source Type: blogs
More News: Anxiety | Arrhythmia | Brain | Bruxism | Cardiology | Chemistry | Child Abuse | Clinical Trials | Depression | Environmental Health | Food and Drug Administration (FDA) | Headache | Heart | Hypertension | Learning | Men | Methamphetamine | Migraine | Mushrooms | Neurology | Neuroscience | Nightmares | Panic Disorder | Post Traumatic Stress Disorder | Psychiatry | Psychotherapy | Sexual Abuse | Sleep Disorders | Sleep Medicine | Stroke | Study | Substance Abuse | Universities & Medical Training | Urology & Nephrology | Women